Literature DB >> 32283950

Dual Role of Hydrogen Peroxide as an Oxidant in Pneumococcal Pneumonia.

Mobarak Abu Mraheil1, Haroldo A Toque2,3, Luigi La Pietra1, Juerg Hamacher4,5,6, Tenzing Phanthok7, Alexander Verin2,7, Joyce Gonzales7, Yunchao Su3, David Fulton2,3, Douglas C Eaton8, Trinad Chakraborty1, Rudolf Lucas2,3,7.   

Abstract

Significance: Streptococcus pneumoniae (Spn), a facultative anaerobic Gram-positive human pathogen with increasing rates of penicillin and macrolide resistance, is a major cause of lower respiratory tract infections worldwide. Pneumococci are a primary agent of severe pneumonia in children younger than 5 years and of community-acquired pneumonia in adults. A major defense mechanism toward Spn is the generation of reactive oxygen species, including hydrogen peroxide (H2O2), during the oxidative burst of neutrophils and macrophages. Paradoxically, Spn produces high endogenous levels of H2O2 as a strategy to promote colonization. Recent Advances: Pneumococci, which express neither catalase nor common regulators of peroxide stress resistance, have developed unique mechanisms to protect themselves from H2O2. Spn generates high levels of H2O2 as a strategy to promote colonization. Production of H2O2 moreover constitutes an important virulence phenotype and its cellular activities overlap and complement those of other virulence factors, such as pneumolysin, in modulating host immune responses and promoting organ injury. Critical Issues: This review examines the dual role of H2O2 in pneumococcal pneumonia, from the viewpoint of both the pathogen (defense mechanisms, lytic activity toward competing pathogens, and virulence) and the resulting host-response (inflammasome activation, endoplasmic reticulum stress, and damage to the alveolar-capillary barrier in the lungs). Future Directions: An understanding of the complexity of H2O2-mediated host-pathogen interactions is necessary to develop novel strategies that target these processes to enhance lung function during severe pneumonia.

Entities:  

Keywords:  ARDS; hydrogen peroxide; pneumococci; pneumonia; pyruvate oxidase; virulence factor

Mesh:

Substances:

Year:  2020        PMID: 32283950      PMCID: PMC8035917          DOI: 10.1089/ars.2019.7964

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  148 in total

1.  The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.

Authors:  P Balachandran; S K Hollingshead; J C Paton; D E Briles
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

Review 2.  Signaling the unfolded protein response from the endoplasmic reticulum.

Authors:  Kezhong Zhang; Randal J Kaufman
Journal:  J Biol Chem       Date:  2004-04-07       Impact factor: 5.157

Review 3.  Role of the fragility of the pulmonary blood-gas barrier in the evolution of the pulmonary circulation.

Authors:  John B West
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-11-28       Impact factor: 3.619

4.  Ethanol-induced alcohol dehydrogenase E (AdhE) potentiates pneumolysin in Streptococcus pneumoniae.

Authors:  Truc Thanh Luong; Eun-Hye Kim; Jong Phil Bak; Cuong Thach Nguyen; Sangdun Choi; David E Briles; Suhkneung Pyo; Dong-Kwon Rhee
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

Review 5.  Alveolar epithelial barrier. Role in lung fluid balance in clinical lung injury.

Authors:  M A Matthay; N Fukuda; J Frank; R Kallet; B Daniel; T Sakuma
Journal:  Clin Chest Med       Date:  2000-09       Impact factor: 2.878

6.  Response of Differentiated Human Airway Epithelia to Alcohol Exposure and Klebsiella Pneumoniae Challenge.

Authors:  Sammeta V Raju; Richard G Painter; Gregory J Bagby; Steve Nelson; Guoshun Wang
Journal:  Med Sci (Basel)       Date:  2013-07-26

7.  TRPV4: an exciting new target to promote alveolocapillary barrier function.

Authors:  Rory E Morty; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-03       Impact factor: 5.464

8.  Future Research Directions in Pneumonia. NHLBI Working Group Report.

Authors:  Charles S Dela Cruz; Richard G Wunderink; David C Christiani; Stephania A Cormier; Kristina Crothers; Claire M Doerschuk; Scott E Evans; Daniel R Goldstein; Purvesh Khatri; Lester Kobzik; Jay K Kolls; Bruce D Levy; Mark L Metersky; Michael S Niederman; Roomi Nusrat; Carlos J Orihuela; Paula Peyrani; Alice S Prince; Julio A Ramírez; Karen M Ridge; Sanjay Sethi; Benjamin T Suratt; Jacob I Sznajder; Ephraim L Tsalik; Allan J Walkey; Sachin Yende; Neil R Aggarwal; Elisabet V Caler; Joseph P Mizgerd
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

9.  Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life?

Authors:  A Carlioz; D Touati
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

Review 10.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23
View more
  3 in total

1.  A maternal high-fat/low-fiber diet impairs glucose tolerance and induces the formation of glycolytic muscle fibers in neonatal offspring.

Authors:  Chengjun Hu; Yunyu Yang; Minxia Chen; Xiangyu Hao; Shuqi Wang; Linfang Yang; Yulong Yin; Chengquan Tan
Journal:  Eur J Nutr       Date:  2021-01-02       Impact factor: 5.614

Review 2.  Streptococcus pneumoniae and Its Virulence Factors H2O2 and Pneumolysin Are Potent Mediators of the Acute Chest Syndrome in Sickle Cell Disease.

Authors:  Joyce Gonzales; Trinad Chakraborty; Maritza Romero; Mobarak Abu Mraheil; Abdullah Kutlar; Betty Pace; Rudolf Lucas
Journal:  Toxins (Basel)       Date:  2021-02-17       Impact factor: 4.546

Review 3.  Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment-From Mice to Men.

Authors:  Andreas von Knethen; Ulrike Heinicke; Volker Laux; Michael J Parnham; Andrea U Steinbicker; Kai Zacharowski
Journal:  Biomedicines       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.